Company: LICN
Filing Date: 2025-01-29
Form Type: 424B5
Source: 0001213900-25-007741
Chunk: 12

Company: Lichen International Ltd
Filing Date: 2025-01-29
Form: 424B5
Chunk 12
---
 the foreseeable
future. Also, as of the date of this prospectus supplement, no cash generated from one subsidiary is used to fund another subsidiary’s
operations and we do not anticipate any difficulties or limitations on our ability to transfer cash between subsidiaries. See “Prospectus
Summary — Transfers of Cash to and from Our Subsidiaries” on page 7 of the accompanying prospectus and “Consolidated
Financial Statements” incorporated by reference into this prospectus.

See “Plan of Distribution”
beginning on page S-30 of this prospectus supplement for more information regarding these arrangements.

We are an “emerging growth company” as defined under federal securities laws and, as such, will be subject to reduced public company reporting requirements. See “Prospectus Summary — Implications of Being an Emerging Growth Company” and “Prospectus Summary — Implications of Being a Foreign Private Issuer” on page 5 of the accompanying prospectus for additional information.

Investing in our securities being offered pursuant to this prospectus involves a high degree of risk. You should carefully read and consider the ‘‘Risk Factors’’ section of this prospectus, and risk factors set forth in our most recent annual report on Form 20-F, in other reports incorporated herein by reference,and in the applicable prospectus supplement before you make your investment decision.

Neither the U.S. Securities and Exchange Commission, the Cayman Islands Monetary Authority, nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

|                                 |     | Per   
 Share |        |     | Per Pre-Funded 
 Warrant        |         |     | Approximate Total (assuming all Pre-Funded Warrants are exercised) |           |
|:--------------------------------|:----|:------|-------:|:----|:---------------|--------:|:----|:-------------------------------------------------------------------|----------:|
| Public offering price           |     | $     |   0.08 |     |                |   0.079 |     | $                                                                  | 3,400,000 |
| Placement Agent Fees            |     | $     | 0.0056 |     |                | 0.00553 |     | $                                                                  |   238,000 |
| Proceeds to us, before expenses |     | $     | 0.0744 |     |                | 0.07347 |     | $                                                                  |